EMAIL THIS PAGE TO A FRIEND

Antimicrobial agents and chemotherapy

RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.


PMID 11036042

Abstract

A collection of rifampin-resistant mutants of Staphylococcus aureus with characterized RNA polymerase beta-subunit (rpoB) gene mutations was cross-screened against a number of other RNA polymerase inhibitors to correlate susceptibility with specific rpoB genotypes. The rpoB mutants were cross-resistant to streptolydigin and sorangicin A. In contrast, thiolutin, holomycin, corallopyronin A, and ripostatin A retained activity against the rpoB mutants. The second group of inhibitors may be of interest as drug development candidates.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T3450
Thiolutin, from Streptomyces luteosporeus, ≥95% (HPLC)
C8H8N2O2S2